Laith L. Yaldoo, Director, 10% Owner at Zivo Bioscience, Inc. (ZIVO), bought 1,766 shares at $8.49 ($15K) on 2026-01-14, disclosed to the SEC on 2026-01-27.
Open-market purchase of $15k ZIVO by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ZIVO | BUY | 2025-12-02 | $25K | — | Filing → |
| ZIVO | BUY | 2025-10-14 | $20K | — | Filing → |
| ZIVO | BUY | 2025-10-02 | $245K | — | Filing → |